Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease

D. Margel; A. Peer; Y. Ber; L. Shavit-Grievink; T. Tabachnik; S. Sela; Felipe Lott

doi:10.1590/S1677-5538.IBJU.2020.05.09

Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease

D. Margel
, A. Peer
, Y. Ber
, L. Shavit-Grievink
, T. Tabachnik
, S. Sela
, Felipe Lott

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	853-854
Number of pages	2
Journal	International Braz J Urol
Volume	46
Issue number	5
DOIs	https://doi.org/10.1590/S1677-5538.IBJU.2020.05.09
State	Published - 1 Sep 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1590/S1677-5538.IBJU.2020.05.09

Cite this

Margel, D., Peer, A., Ber, Y., Shavit-Grievink, L., Tabachnik, T., Sela, S., & Lott, F. (2020). Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease. International Braz J Urol, 46(5), 853-854. https://doi.org/10.1590/S1677-5538.IBJU.2020.05.09

@article{7379b3e4a6f04d868e18a67756c6dae8,

title = "Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease",

author = "D. Margel and A. Peer and Y. Ber and L. Shavit-Grievink and T. Tabachnik and S. Sela and Felipe Lott",

year = "2020",

month = sep,

day = "1",

doi = "10.1590/S1677-5538.IBJU.2020.05.09",

language = "אנגלית",

volume = "46",

pages = "853--854",

journal = "International Braz J Urol",

issn = "1677-5538",

publisher = "Brazilian Society of Urology",

number = "5",

}

Margel, D, Peer, A, Ber, Y, Shavit-Grievink, L, Tabachnik, T, Sela, S & Lott, F 2020, 'Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease', International Braz J Urol, vol. 46, no. 5, pp. 853-854. https://doi.org/10.1590/S1677-5538.IBJU.2020.05.09

Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease. / Margel, D.; Peer, A.; Ber, Y. et al.
In: International Braz J Urol, Vol. 46, No. 5, 01.09.2020, p. 853-854.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Editorial comment

T2 - Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease

AU - Margel, D.

AU - Peer, A.

AU - Ber, Y.

AU - Shavit-Grievink, L.

AU - Tabachnik, T.

AU - Sela, S.

AU - Lott, Felipe

PY - 2020/9/1

Y1 - 2020/9/1

UR - https://www.scopus.com/pages/publications/85087820255

U2 - 10.1590/S1677-5538.IBJU.2020.05.09

DO - 10.1590/S1677-5538.IBJU.2020.05.09

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 32648429

AN - SCOPUS:85087820255

SN - 1677-5538

VL - 46

SP - 853

EP - 854

JO - International Braz J Urol

JF - International Braz J Urol

IS - 5

ER -

Editorial comment: Cardiovascular morbidity in a randomized trial comparing GnRH agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease

UN SDGs

Access to Document

Other files and links

Cite this